More articles from INTEGRATED Session: Neuroendocrine Highlights

You have access
Quantitative analysis with ¹²³I-MIBG SPECT/CT for pheochromocytoma and paraganglioma
Ryusuke Nakamoto, Yuji Nakamoto, Takayoshi Ishimori, Koya Nakatani and Kaori Togashi

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 147;
You have access
A theranostic approach for adrenocortical neoplasia based on high adrenal CXCR4 expression.
Christina Bluemel, Constantin Lapa, Andreas Schirbel, Martin Fassnacht, Bruno Allolio, Margret Schottelius, S. Kropf, Hans Wester, Stefanie Hahner and Ken Herrmann

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 145;
You have access
⁶⁸Ga-exendin-4 PET/CT is highly effective in localizing insulinomas
Yaping Luo, Fang Li and Zhaohui Zhu

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 146;
You have access
Localisation of Insulinoma: Comparison of Glucagon-like Peptide-1 Receptor (GLP1-R) SPECT/CT, PET/CT and MRI. Preliminary results of a prospective clinical study.
Kwadwo Antwi, Melpomeni Fani, Tobias Heye, Guillaume Nicolas, Elmar Merkle, Jean Claude Reubi, Beat Gloor, Emanuel Christ and Damian Wild

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 144;
You have access
Intrapatient ⁶⁸Ga-DOTATOC/⁶⁸Ga-DOTATATE uptake comparison in primary neuroendocrine tumors, metastases and normal liver.
Mila Todorović-Tirnanić, Milan Gajić and Richard Baum

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 148;
You have access
Role of Gallium-68 DOTATOC PET-CT in Neuroendocrine Tumors with Unknown Primary Site
Yusuf Menda, Thomas O'Dorisio, Michael Graham, James Howe, David Dick, Joseph Dillon, Michael Schultz, Gordon Watkins, John Sunderland and M Sue O'Dorisio

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 143;

Main menu

User menu

Search

More articles from INTEGRATED Session: Neuroendocrine Highlights